Protagonist Therapeutics Inc (PTGX)

Finanzdaten der Protagonist Therapeutics Inc-Aktie (PTGX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	278.72%213.48	56.37	7.44	4.71	5.55
	8.84%54.71	60.02	57.79	51.13	47.59
Research and Development	10.01%42.06	46.74	46.36	40.00	37.04
Operating Income/Loss	4,452%158.77	-3.65	-50.36	-46.42	-42.04
Income/Loss From Continuing Operations Before Tax	7,139%165.11	2.28	-43.72	-39.34	-34.60
Income Tax Expense/Benefit	250.80%2.27	-1.50	0.67	-	0.17
	4,205%162.85	3.78	-44.38	-39.34	-34.77
Attributable To Parent	4,205%162.85	3.78	-44.38	-39.34	-34.77
Basic Average Shares	1.30%65.94	65.09	0.15	63.77	63.51
Diluted Average Shares	0.73%71.01	70.49	0.15	63.77	63.51
Basic Earnings Per Share	4,017%2.47	0.06	-0.70	-0.62	-0.55
Diluted Earnings Per Share	4,480%2.29	0.05	-0.70	-0.62	-0.55